Literature DB >> 12554794

Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling.

Venkatesh Krishnan1, Terry L Moore, Yanfei L Ma, Leah M Helvering, Charles A Frolik, Kathleen M Valasek, Patricia Ducy, Andrew G Geiser.   

Abstract

The Cbfa1/Runx2 (referred to herein as Cbfa1) transcription factor has been shown to be essential for osteoblast differentiation and bone formation during embryogenesis. PTH given intermittently is a proven bone anabolic agent. Here, we investigated whether PTH regulates the expression and/or activity of Cbfa1 in osteoblastic cells and in a rat metatarsal organ culture assay. PTH was found to regulate Cbfa1 mRNA in the rat osteosarcoma cell line UMR106 in a concentration-dependent manner. The effect of PTH was mimicked by forskolin, an activator of adenylate cyclase leading to the protein kinase A pathway. PTH administered intermittently for 5 d in vivo was found to stimulate Cbfa1 protein in the rat proximal tibiae metaphysis. To demonstrate PTH regulation of Cbfa1 activity, a construct containing six tandem Cbfa1 binding elements fused to luciferase was shown to be rapidly stimulated in response to PTH. This stimulation preceded the effects on mRNA regulation and resulted from a protein kinase A-mediated increase in Cbfa1 activity. Finally, using a neonate rat metatarsal organ culture system, we demonstrated dose-dependent anabolic responsiveness to PTH and to Cbfa1 overexpression from an adenoviral construct. We further showed that Cbfa1 antisense oligonucleotides that blocked adenoviral Cbfa1-induced anabolic effects in this organ culture model also abolished the PTH-mediated anabolic increase. These findings suggest a requirement for Cbfa1 in mediating the anabolic effects of PTH. Thus, regulation of Cbfa1 expression or activity is an important mechanism by which PTH controls osteoblast function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12554794     DOI: 10.1210/me.2002-0225

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  44 in total

1.  Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition.

Authors:  Aditi Mukherjee; Emily A Larson; Amy S Carlos; John K Belknap; Peter Rotwein; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-06       Impact factor: 6.741

Review 2.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

3.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 4.  Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.

Authors:  T J Martin; N A Sims; K W Ng
Journal:  Osteoporos Int       Date:  2008-03-13       Impact factor: 4.507

5.  Akt promotes BMP2-mediated osteoblast differentiation and bone development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

6.  Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation.

Authors:  Nagarajan Selvamurugan; Emi Shimizu; Minnkyong Lee; Tong Liu; Hong Li; Nicola C Partridge
Journal:  FEBS Lett       Date:  2009-03-03       Impact factor: 4.124

Review 7.  Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis.

Authors:  Ritsuko Masuyama
Journal:  J Bone Miner Metab       Date:  2013-11-09       Impact factor: 2.626

8.  Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2008-02-21

9.  The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.

Authors:  Antonio Casado-Diaz; Raquel Santiago-Mora; José Manuel Quesada
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

10.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.